Company news

ProKidney Corp. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

June 12, 2023

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

May 31, 2023

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

May 10, 2023

ProKidney to Present at the BofA Securities Health Care Conference 2023

May 3, 2023

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

March 27, 2023

ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference

March 2, 2023

ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease

January 9, 2023

ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference

December 21, 2022

ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights

November 13, 2022

ProKidney to Participate in Upcoming Investor Conferences

November 10, 2022

ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease

November 2, 2022

ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2022

October 13, 2022

ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit

September 22, 2022

ProKidney to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

September 7, 2022

ProKidney Appoints Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations

August 30, 2022

ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox

August 10, 2022

ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update

August 10, 2022

ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs

July 19, 2022

Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders

July 7, 2022

Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 Update

June 6, 2022

ProKidney to present at upcoming investor conferences

May 19, 2022

ProKidney and Social Capital Suvretta Holdings Corp. III (“SCS”) to Host Analyst and Investor Day on April 28, 2022

April 17, 2022

ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT®

April 11, 2022

ProKidney Announces Online Publication of Trial Design for Phase II Multicenter Clinical Trial of REACT® Autologous Cell Therapy for Treatment of Chronic Kidney Disease

January 26, 2022

Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III

January 17, 2022

← Newer news releases

Decks

The 5 newest of 21 decks. Every deck is listed under its year.